Institutional Ownership Cytosorbents Corp (CTSO)
This table provides information about the institutional ownership of Cytosorbents Corp (CTSO). We have compiled data on the 57 institutions that hold shares in the stock, with a total of 16.8 Million shares, which have been reported (via 13F filing form) to have a value of $11.8 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Jpmorgan Chase & CO
New York, NY |
Nov 26, 2025 Q3 2025 |
372
shares
|
$260
0.0% of portfolio
|
Q3 2025
Reduced 23.3%
|
|
|
Your Advocates Ltd., LLP
Houston, TX |
Nov 03, 2025 Q3 2025 |
250
shares
|
$175
0.0% of portfolio
|
Q1 2021
New holding
|
|
|
Mai Capital Management
|
Nov 10, 2025 Q3 2025 |
233
shares
|
$163
0.0% of portfolio
|
Q1 2025
Added 126.21%
|
|
|
Harvest Group Wealth Management, LLC
|
Apr 28, 2023 Q1 2023 |
37
shares
|
$25
0.0% of portfolio
|
Q2 2022
New holding
|
|
|
Pnc Financial Services Group, Inc.
Pittsburgh, PA |
Nov 07, 2025 Q3 2025 |
31
shares
|
$21
0.0% of portfolio
|
Q1 2024
Reduced 13.89%
|
|
|
Sbi Securities Co., Ltd.
Tokyo, M0 |
Nov 04, 2025 Q3 2025 |
1
shares
|
$0
0.0% of portfolio
|
Q3 2025
Reduced 99.0%
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Aug 12, 2025 Q2 2025 |
0
shares
|
$0
100.0% of portfolio
|
Q2 2025
New holding
|